Vanda Pharmaceuticals Inc (VNDA)
4.88
+0.20
(+4.27%)
USD |
NASDAQ |
May 03, 16:00
5.05
+0.17
(+3.48%)
After-Hours: 20:00
Vanda Pharmaceuticals Gross Profit (Quarterly): 41.81M for Dec. 31, 2023
Gross Profit (Quarterly) Chart
Historical Gross Profit (Quarterly) Data
Date | Value |
---|---|
December 31, 2023 | 41.81M |
September 30, 2023 | 35.75M |
June 30, 2023 | 42.56M |
March 31, 2023 | 57.72M |
December 31, 2022 | 58.24M |
September 30, 2022 | 59.00M |
June 30, 2022 | 58.33M |
March 31, 2022 | 54.53M |
December 31, 2021 | 61.78M |
September 30, 2021 | 63.30M |
June 30, 2021 | 61.33M |
March 31, 2021 | 56.64M |
December 31, 2020 | 61.24M |
September 30, 2020 | 54.41M |
June 30, 2020 | 56.36M |
March 31, 2020 | 52.79M |
December 31, 2019 | 54.70M |
September 30, 2019 | 52.70M |
June 30, 2019 | 52.69M |
March 31, 2019 | 42.60M |
December 31, 2018 | 47.37M |
September 30, 2018 | 44.07M |
June 30, 2018 | 42.14M |
March 31, 2018 | 39.03M |
December 31, 2017 | 39.48M |
Date | Value |
---|---|
September 30, 2017 | 36.81M |
June 30, 2017 | 37.53M |
March 31, 2017 | 33.41M |
December 31, 2016 | 32.97M |
September 30, 2016 | 31.49M |
June 30, 2016 | 29.54M |
March 31, 2016 | 27.31M |
December 31, 2015 | 25.68M |
September 30, 2015 | 21.83M |
June 30, 2015 | 21.82M |
March 31, 2015 | 17.14M |
December 31, 2014 | 14.69M |
September 30, 2014 | 14.08M |
June 30, 2014 | 10.66M |
March 31, 2014 | 9.143M |
December 31, 2013 | 8.783M |
September 30, 2013 | 8.709M |
June 30, 2013 | 8.319M |
March 31, 2013 | |
December 31, 2012 | |
September 30, 2012 | |
June 30, 2012 | |
March 31, 2012 | |
December 31, 2011 | 8.37M |
September 30, 2011 | 7.969M |
Gross Profit Definition
Gross profit is the difference between sales and the cost of goods sold. Revenues (aka Sales) less Cost of Goods Sold (COGS) is a company's gross profit. For many companies, cost of goods sold is a substantial portion of expenses.
Gross Profit (Quarterly) Range, Past 5 Years
35.75M
Minimum
Sep 2023
63.30M
Maximum
Sep 2021
54.52M
Average
56.36M
Median
Jun 2020
Gross Profit (Quarterly) Benchmarks
ADMA Biologics Inc | 31.09M |
INVO Bioscience Inc | 0.495M |
Johnson & Johnson | 14.87B |
Nektar Therapeutics | 16.60M |
Invivyd Inc | -- |